Рет қаралды 7,357
Donate to PCRI: pcri.org/donate
In this free PCRI webinar Mark Moyad, MD, MPH sits down with Laurence Klotz, MD, to discuss active surveillance and a new type of focal therapy TULSA PRO. The most common treatments for localized prostate cancer treat the entire gland (i.e. radical prostatectomy and radiation). Focal therapies (e.g. TULSA PRO, HIFU, cryotherapy, electroporation, and focal radiation) treat a portion of the gland to control a tumor-if the tumor fits certain criteria-with less risk of urinary and sexual side effects than whole gland therapy. They will cover details about this new treatment and discuss the pros and cons.
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's KZbin channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. Opinions stated within this video belongs solely to the speaker and does not represent PCRI. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#prostatecancer #laurenceklotzmd #markmoyadmd